Yüklüyor......
The role of plasma genotyping in ALK- and ROS1-rearranged lung cancer
Several subsets of non-small cell lung cancer (NSCLC) are defined by the presence of oncogenic rearrangements that result in constitutive activation of a chimeric fusion protein. In NSCLCs that harbor ALK or ROS1 rearrangements, aberrant signaling from these fusion proteins can be overcome by potent...
Kaydedildi:
| Yayımlandı: | Transl Lung Cancer Res |
|---|---|
| Asıl Yazarlar: | , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
AME Publishing Company
2020
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7815348/ https://ncbi.nlm.nih.gov/pubmed/33489818 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tlcr-2019-cnsclc-09 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|